EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

An In Vitro Study of Differentiation of Hematopoietic Cells to Endothelial Cells

Qi Ru Wang, Bao He Wang, Wen Biao Zhu, Yan Hong Huang, Yi Li, Qi Yan

Bone Marrow Research · 2011

DOI: 10.1155/2011/846096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bone Marrow Research, 2011. Verfasst von Qi Ru Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Xiangya Medical College, Central South University, Changsha 410078, China. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NEI NIH HHS, National Natural Science Foundation of China, National Institutes of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone-marrow-derived endothelial progenitor cells (BM-EPCs) contribute to postnatal neovascularization and therefore are of great interest for cell therapies to treat ischemic diseases. However, their origin and characteristics are still in controversy. In this paper, we identified the origin/lineage of the BM-EPCs that were isolated from bone marrow mononuclear cells and differentiated with the induction of bone-marrow endothelial-cellconditioned medium (ECCM). BM-EPCs were characterized in terms of phenotype, lineage potential, and their functional properties. Endothelial cell colonies derived from BM-EPC were cultured with ECCM for 3 months. Cultured EPC colony cells expressed endothelial cell markers and formed the capillary-like network in vitro . EPC colony cells expressed differential proliferative capacity; some of the colonies exhibited a high proliferative potential (HPP) capacity up to 20 population doublings. More importantly, these HPP-EPCs expressed hematopoietic marker CD45, exhibited endocytic activities, and preserved some of the myeloid cell activity. In addition, the HPP-EPCs secrete various growth factors including VEGF and GM-CSF into the culture medium. The results demonstrate that these EPCs were primarily derived from hematopoietic origin of early precursor cells and maintained high proliferative potential capacity, a feature with a significant potential in the application of cell therapy in ischemic diseases.

Autor:innen und Institutionen

  • Department of Physiology, Xiangya Medical College, Central South University, Changsha 410078, China.

Förderung

  • NEI NIH HHS
  • National Natural Science Foundation of China
  • National Institutes of Health

Zitieren

APA

Wang, Q. R., Wang, B. H., Zhu, W. B., Huang, Y. H., Li, Y., & Yan, Q. (2011). An In Vitro Study of Differentiation of Hematopoietic Cells to Endothelial Cells. Bone Marrow Research. https://doi.org/10.1155/2011/846096

Vancouver

Wang QR, Wang BH, Zhu WB, Huang YH, Li Y, Yan Q. An In Vitro Study of Differentiation of Hematopoietic Cells to Endothelial Cells. Bone Marrow Research. 2011. doi:10.1155/2011/846096

BibTeX
@article{Wang2011,
  author = {Wang, Qi Ru and Wang, Bao He and Zhu, Wen Biao and Huang, Yan Hong and Li, Yi and Yan, Qi},
  title = {An In Vitro Study of Differentiation of Hematopoietic Cells to Endothelial Cells},
  journal = {Bone Marrow Research},
  year = {2011},
  doi = {10.1155/2011/846096}
}
Kostenlos starten →